$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024041274 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$96.00K	$71.00K
YoY Change	-12.73%	-18.39%
Cost Of Revenue	$4.000K
YoY Change	-60.0%
Gross Profit	$92.00K
YoY Change	-8.0%
Gross Profit Margin	95.83%
Selling, General & Admin	$2.731M	$2.511M
YoY Change	-12.47%	-16.85%
% of Gross Profit	2968.48%
Research & Development	$3.714M	$3.094M
YoY Change	-7.15%	-28.59%
% of Gross Profit	4036.96%
Depreciation & Amortization	$61.00K	$61.00K
YoY Change	-12.86%	-30.68%
% of Gross Profit	66.3%
Operating Expenses	$5.736M	$3.094M
YoY Change	-13.74%	-28.59%
Operating Profit	-$5.644M	-$5.534M
YoY Change	-13.83%	-22.06%
Interest Expense	-$218.0K	$218.0K
YoY Change	263.33%	-200.46%
% of Operating Profit
Other Income/Expense, Net	$390.0K	$144.0K
YoY Change		-132.65%
Pretax Income	-$5.862M	-$5.390M
YoY Change	-11.32%	-30.52%
Income Tax
% Of Pretax Income
Net Earnings	-$5.729M	-$5.293M
YoY Change	-13.33%	-30.57%
Net Earnings / Revenue	-5967.71%	-7454.93%
Basic Earnings Per Share		-$1.01
Diluted Earnings Per Share	-$1.07	-$1.01
COMMON SHARES
Basic Shares Outstanding	5.389M shares	41.48M shares
Diluted Shares Outstanding		5.221M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.99M	$26.01M
YoY Change	-25.35%	-41.12%
Cash & Equivalents	$6.783M	$7.081M
Short-Term Investments	$23.20M	$18.93M
Other Short-Term Assets	$1.122M	$1.360M
YoY Change	-0.71%	-46.01%
Inventory
Prepaid Expenses	$222.0K
Receivables
Other Receivables
Total Short-Term Assets	$31.11M	$27.37M
YoY Change	-24.88%	-41.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$688.0K	$769.0K
YoY Change	0.0%	12.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$70.00K	$7.000K
YoY Change	6900.0%	250.0%
Total Long-Term Assets	$8.420M	$9.023M
YoY Change	-10.31%	-5.56%
TOTAL ASSETS
Total Short-Term Assets	$31.11M	$27.37M
Total Long-Term Assets	$8.420M	$9.023M
Total Assets	$39.53M	$36.39M
YoY Change	-22.19%	-35.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$964.0K	$1.030M
YoY Change	-46.74%	-29.11%
Accrued Expenses	$1.223M	$958.0K
YoY Change	1.16%	-28.24%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.454M	$4.526M
YoY Change	-20.76%	-15.83%
LONG-TERM LIABILITIES
Long-Term Debt	$24.03M	$24.07M
YoY Change	2.11%	3.08%
Other Long-Term Liabilities	$5.631M	$5.954M
YoY Change	-11.32%	-10.29%
Total Long-Term Liabilities	$29.66M	$30.02M
YoY Change	-0.73%	0.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.454M	$4.526M
Total Long-Term Liabilities	$29.66M	$30.02M
Total Liabilities	$34.11M	$34.55M
YoY Change	-3.9%	-2.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$420.5M	-$414.7M
YoY Change	5.23%	5.5%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$96.00K	-$356.0K
YoY Change
Total Liabilities & Shareholders Equity	$39.53M	$36.39M
YoY Change	-22.19%	-35.3%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$5.729M	-$5.293M
YoY Change	-13.33%	-30.57%
Depreciation, Depletion And Amortization	$61.00K	$61.00K
YoY Change	-12.86%	-30.68%
Cash From Operating Activities	-$4.313M	-$4.202M
YoY Change	48.72%	-30.79%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$89.00K
YoY Change	-88.89%	270.83%
Acquisitions
YoY Change
Other Investing Activities	-$4.795M	$5.757M
YoY Change	-208.48%	-445.97%
Cash From Investing Activities	-$4.805M	$5.668M
YoY Change	-210.97%	-435.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.841M	0.000
YoY Change	-88510.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-4.313M	-4.202M
Cash From Investing Activities	-4.805M	5.668M
Cash From Financing Activities	8.841M	0.000
Net Change In Cash	-277.0K	1.466M
YoY Change	-119.51%	-127.06%
FREE CASH FLOW
Cash From Operating Activities	-$4.313M	-$4.202M
Capital Expenditures	$10.00K	$89.00K
Free Cash Flow	-$4.323M	-$4.291M
YoY Change	44.58%	-29.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.04
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4993451	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.01
	dei	Entity Registrant Name EntityRegistrantName	PLURI INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0351734
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3508409
	dei	Security12b Title Security12bTitle	Common Shares, par value $0.00001
	dei	Trading Symbol TradingSymbol	PLUR
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5221162	shares
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	637000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-31392
	dei	Entity Address Address Line1 EntityAddressAddressLine1	MATAM Advanced Technology Park
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building No. 5
	dei	Entity Address City Or Town EntityAddressCityOrTown	Haifa
	dei	Entity Address Country EntityAddressCountry	IL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5388792	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7081000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5360000	usd
CY2024Q1	plur	Shortterm Bank Deposits ShorttermBankDeposits	18926000	usd
CY2023Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	34811000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	273000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	269000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1087000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	969000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	27367000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	41409000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	627000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50797000	usd
CY2024Q1	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	459000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	439000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	769000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7151000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	9023000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	9388000	usd
CY2024Q1	us-gaap	Assets Assets	36390000	usd
CY2023Q2	us-gaap	Assets Assets	50797000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1030000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1812000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	958000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1209000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	675000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2024Q1	plur	Accrued Vacations Current AccruedVacationsCurrent	810000	usd
CY2023Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	873000	usd
CY2024Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	101000	usd
CY2023Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	7000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	952000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1093000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4526000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5621000	usd
CY2024Q1	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	611000	usd
CY2023Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	598000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5343000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2024Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	24065000	usd
CY2023Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23530000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30019000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29876000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37500000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37500000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5228737	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5228737	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5155687	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5155687	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	414387000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	412939000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-414743000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399584000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-356000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13355000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	2201000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1945000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1845000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36390000	usd
	us-gaap	Revenues Revenues	230000	usd
	us-gaap	Revenues Revenues	176000	usd
CY2024Q1	us-gaap	Revenues Revenues	71000	usd
CY2023Q1	us-gaap	Revenues Revenues	87000	usd
	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	10066000	usd
	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	13412000	usd
CY2024Q1	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	3362000	usd
CY2023Q1	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	4333000	usd
	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1015000	usd
	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1189000	usd
CY2024Q1	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	268000	usd
CY2023Q1	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	166000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9051000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12223000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4167000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7303000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8655000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2511000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3020000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16124000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20702000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5534000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7100000	usd
	us-gaap	Interest Expense InterestExpense	648000	usd
	us-gaap	Interest Expense InterestExpense	623000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	218000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	217000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1290000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-956000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	362000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-441000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	642000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1579000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	144000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-658000	usd
	us-gaap	Profit Loss ProfitLoss	-15482000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-5390000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-323000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-419000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-97000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-134000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15159000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21862000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-5293000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-7624000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.92
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.04
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.52
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5193808	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4402130	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5221162	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4993451	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2942000	usd
	plur	Net Of Issuance Costs NetOfIssuanceCosts	435000	usd
	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	8034000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24966000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1045000	usd
CY2023Q1	plur	Net Of Issuance Costs NetOfIssuanceCosts	74000	usd
CY2023Q1	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	2628000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7758000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20881000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2027000	usd
	us-gaap	Profit Loss ProfitLoss	-15482000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1845000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6617000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	618000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-5390000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1845000	usd
	us-gaap	Profit Loss ProfitLoss	-15482000	usd
	us-gaap	Profit Loss ProfitLoss	-22281000	usd
	us-gaap	Depreciation Depreciation	192000	usd
	us-gaap	Depreciation Depreciation	285000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2027000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2942000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	124000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	510000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-742000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-393000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-455000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1135000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	94000	usd
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	7000	usd
	plur	Increasedecrease In Operating Lease Rightofuse Asset And Liability Net IncreasedecreaseInOperatingLeaseRightofuseAssetAndLiabilityNet	-125000	usd
	plur	Increasedecrease In Operating Lease Rightofuse Asset And Liability Net IncreasedecreaseInOperatingLeaseRightofuseAssetAndLiabilityNet	2000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-218000	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	786000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-89000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	278000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	535000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1668000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-7000	usd
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-33000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13708000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19960000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	313000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165000	usd
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-15702000	usd
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-5539000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	15389000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5374000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8034000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8034000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-278000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1735000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6830000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7991000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4583000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7081000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3677000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	273000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	273000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	637000	usd
CY2023Q1	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	633000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7991000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4583000	usd
	plur	Purchase Of Propertys And Equipment On Credit PurchaseOfPropertysAndEquipmentOnCredit	34000	usd
	plur	Purchase Of Propertys And Equipment On Credit PurchaseOfPropertysAndEquipmentOnCredit	87000	usd
	plur	Accrued Expenses Related To Issuance Of Common Shares And Warrants AccruedExpensesRelatedToIssuanceOfCommonSharesAndWarrants	100000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	82000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	216000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	87000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-414743000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-356000	usd
	us-gaap	Profit Loss ProfitLoss	-15482000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13708000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	26917000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c.</i></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2021Q2	plur	Due Date DueDate	2026-06-01
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	910000	usd
	plur	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
	plur	Royalty Rate Sales RoyaltyRateSales	0.03	pure
	plur	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
CY2024Q1	plur	Contingent Liability In Respect To Royalties ContingentLiabilityInRespectToRoyalties	27746000	usd
CY2021Q2	plur	Due Date DueDate	2026-06-01
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21620000	usd
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1019488	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1019488	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.24
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	697486	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	697486	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.24
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.4
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	258565	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	258565	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.4
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.48
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	29688	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	29688	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.48
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.72
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	16875	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	16875	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.72
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.96
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	16875	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	16875	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.96
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2023Q4	plur	Aggregate Amount Received AggregateAmountReceived	2500000	usd
CY2023Q1	us-gaap	Common Unit Issued CommonUnitIssued	10000	shares
CY2023Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	1000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	310000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	10000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	310000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	117000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	149000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	43000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5193808	shares
	plur	Modification Of Warrants To Noncontrolling Interests ModificationOfWarrantsToNoncontrollingInterests		usd
	plur	Expiration Of Warrants In Ever After ExpirationOfWarrantsInEverAfter		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	plur	Accrued Expenses Related To Issuance Of Common Shares And Warrants AccruedExpensesRelatedToIssuanceOfCommonSharesAndWarrants		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-24-041274-index-headers.html	Edgar Link	pending
0001213900-24-041274-index.html	Edgar Link	pending
0001213900-24-041274.txt	Edgar Link	pending
0001213900-24-041274-xbrl.zip	Edgar Link	pending
ea0205163-10q_pluriinc.htm	Edgar Link	pending
ea020516301ex3-3_pluriinc.htm	Edgar Link	pending
ea020516301ex3-4_pluriinc.htm	Edgar Link	pending
ea020516301ex31-1_pluriinc.htm	Edgar Link	pending
ea020516301ex31-2_pluriinc.htm	Edgar Link	pending
ea020516301ex32-1_pluriinc.htm	Edgar Link	pending
ea020516301ex32-2_pluriinc.htm	Edgar Link	pending
ea0205163-10q_pluriinc_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plur-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
plur-20240331_cal.xml	Edgar Link	unprocessable
plur-20240331_def.xml	Edgar Link	unprocessable
plur-20240331_lab.xml	Edgar Link	unprocessable
plur-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2024 Q2 Form 10-Q Financial Statement

#000121390024041274 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2024 Q2 Form 10-Q Financial Statement

#000121390024041274 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur